Breaking News Instant updates and real-time market news.

HLF

Herbalife Nutrition

$54.71

0.455 (0.84%)

16:20
10/30/18
10/30
16:20
10/30/18
16:20

Herbalife Nutrition announces new $1.5B share repurchase program

Herbalife Nutrition announces board approval of a new five year $1.5B share repurchase program.

  • 30

    Oct

  • 31

    Oct

HLF Herbalife Nutrition
$54.71

0.455 (0.84%)

10/09/18
DADA
10/09/18
INITIATION
Target $92
DADA
Buy
Nu Skin initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser initiated Nu Skin (NUS) with a Buy rating and a price target of $92, forecasting a 13% organic sales growth and 24% earnings growth in FY18. The analyst notes the achievements of the company's new CEO and CFO in shifting its focus to customer acquisition through "engaging Platforms that leverage social selling, enabling Products that are demonstrable online, and empowering programs to optimize sales performance." Weiser also points to Nu Skin's attractive valuation at 9.0-times her expected FY19 EBITDA - a discount to Herbalife (HLF) and USANA (USNA) which trade around 11-times.
10/11/18
JEFF
10/11/18
INITIATION
Target $65
JEFF
Buy
Herbalife Nutrition initiated with a Buy at Jefferies
Jefferies analyst Akshay Jagdale started Herbalife Nutrition with a Buy rating and $65 price target. After a period of "muted growth," Herbalife's sales looked poised to accelerate to a more normalized range of 5%-9%, Jagdale tells investors in a research note. He thinks the company should be able to grow at least in line with its total addressable market growth rate of 6%. This, coupled with margin expansion and accretive free cash flow usage, should drive "significant" earnings upside and support a "growth company valuation," Jagdale contends.
10/11/18
10/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sage Therapeutics (SAGE) initiated with an Outperform at Oppenheimer. 2. Herbalife Nutrition (HLF) initiated with a Buy at Jefferies. 3. GreenSky (GSKY) initiated with a Buy at BTIG. 4. Nightstar Therapeutics (NITE) initiated with an Overweight at Cantor Fitzgerald. 5. KLX Energy (KLXE) initiated with a Buy at Gabelli. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/11/18
10/11/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. JPMORGAN UPGRADES LUMENTUM AFTER SELLOFF: JPMorgan analyst Samik Chatterjee upgraded Lumentum (LITE) to Overweight from Neutral with an unchanged price target of $80. The 19% stock decline from the highs in late August, driven by concerns relative to U.S.-China trade, over-appreciates the "modest risks" for Lumentum, Chatterjee said. He believes this creates an "attractive buying opportunity" to capitalize on the near-term improvement in the earnings outlook. GOLDMAN CUTS HUNTINGTON TO SELL: Goldman Sachs analyst Noah Poponak downgraded Huntington Ingalls Industries (HII) to Sell from Neutral and lowered his price target for the shares to $208 from $220. Poponak said Huntington is now the most expensive stock in his Defense coverage on economic, price-to-earnings and free cash flow yield. The analyst believes the stock could underperform Defense peers in the medium-term given the valuation. JEFFRIES STARTS HERBALIFE WITH A BUY: Jefferies analyst Akshay Jagdale started Herbalife Nutrition (HLF) with a Buy rating and $65 price target. After a period of "muted growth," Herbalife's sales looked poised to accelerate to a more normalized range of 5%-9%, Jagdale believes. He thinks the company should be able to grow at least in line with its total addressable market growth rate of 6%. This, coupled with margin expansion and accretive free cash flow usage, should drive "significant" earnings upside and support a "growth company valuation," Jagdale said. JPMORGAN RAISES PRICE TARGET ON NY TIMES: JPMorgan analyst Alexia Quadrani raised her price target for New York Times (NYT) to $32 and reiterated an Overweight rating on the shares ahead of the company's Q3 results. The analyst said that while quarterly subscriber growth may continue to be volatile, the company's longer-term trends are positive. She expects New York Times' growth to "remain at elevated levels for the foreseeable future." SNAP PRICE TARGET CUT AT GOLDMAN SACHS: Goldman Sachs analyst Heath Terry lowered his price target for Snap (SNAP) to $11 from $17, while reiterating a Buy rating on the shares. With Snap shares down 50% since the company reported Q2 results, beyond the broader weakness in social media, the analyst believes investors are clearly focused on the impact competition is having on the company's user growth, ability to monetize, and capital needs. Terry continues to believe that a Twitter-like (TWTR) turnaround is possible, particularly as the new Android app comes out of Alpha later this quarter. However, it is unlikely that Q3 results will show any signs of that as reported DAUs decline and engagement is negatively impacted by the redesign/competition, he said.

TODAY'S FREE FLY STORIES

AAPL

Apple

$172.39

1.27 (0.74%)

15:55
02/22/19
02/22
15:55
02/22/19
15:55
Periodicals
Apple to shutter stores in Eastern District of Texas, MacRumors reports »

Apple intends to shutter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 01

    Mar

DPLO

Diplomat Pharmacy

$5.67

-7.79 (-57.88%)

15:54
02/22/19
02/22
15:54
02/22/19
15:54
Downgrade
Diplomat Pharmacy rating change  »

Diplomat Pharmacy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 11

    Mar

  • 12

    Mar

LIN

Linde plc

$173.06

1.65 (0.96%)

, LYB

LyondellBasell

$88.93

0.42 (0.47%)

15:51
02/22/19
02/22
15:51
02/22/19
15:51
Hot Stocks
FTC approves Linde's application for sale of plant to LyondellBasell »

The Federal Trade…

LIN

Linde plc

$173.06

1.65 (0.96%)

LYB

LyondellBasell

$88.93

0.42 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MGEE

MGE Energy

$66.40

0.42 (0.64%)

15:50
02/22/19
02/22
15:50
02/22/19
15:50
Earnings
MGE Energy reports Q4 EPS 47c vs. $1.04 last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KPTI

Karyopharm

$4.91

-4.05 (-45.20%)

15:50
02/22/19
02/22
15:50
02/22/19
15:50
Options
44% dive in shares motivates interest in KKaryopharm far upside calls »

44% dive in shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

  • 06

    Apr

NESR

National Energy Services

$8.75

0.005 (0.06%)

15:48
02/22/19
02/22
15:48
02/22/19
15:48
Syndicate
Breaking Syndicate news story on National Energy Services »

National Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

NIO

NIO Inc.

$7.97

0.355 (4.66%)

15:44
02/22/19
02/22
15:44
02/22/19
15:44
Periodicals
CBS teases upcoming 60 Minutes feature on NIO Inc. »

The 60 Minutes report,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Mar

BRK.A

Berkshire Hathaway

$302,770.46

-5154.54 (-1.67%)

, BRK.B

Berkshire Hathaway

$201.90

-3.41 (-1.66%)

15:39
02/22/19
02/22
15:39
02/22/19
15:39
Periodicals
Berkshire Hathaway in advanced talks to sell Applied Underwriters, Reuters says »

Berkshire Hathaway is in…

BRK.A

Berkshire Hathaway

$302,770.46

-5154.54 (-1.67%)

BRK.B

Berkshire Hathaway

$201.90

-3.41 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTW

WW

$29.34

0.27 (0.93%)

15:35
02/22/19
02/22
15:35
02/22/19
15:35
Options
Weight Watchers put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

15:35
02/22/19
02/22
15:35
02/22/19
15:35
General news
U.S. Treasury Market Summary »

U.S. Treasury Market…

15:28
02/22/19
02/22
15:28
02/22/19
15:28
Conference/Events
House Financial Services Committee to hold a hearing »

The Committee holds a…

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

, RUT

Russell 2000 Index

$0.00

(0.00%)

15:22
02/22/19
02/22
15:22
02/22/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

For the holiday-shortened…

IWM

iShares Trust Russell 2000 Index Fund

$157.79

1 (0.64%)

RUT

Russell 2000 Index

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$55.68

0.14 (0.25%)

, XLE

Energy Select Sector SPDR

$65.66

0.1 (0.15%)

15:22
02/22/19
02/22
15:22
02/22/19
15:22
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

At time of writing the…

XLB

S&P Select Materials SPDR

$55.68

0.14 (0.25%)

XLE

Energy Select Sector SPDR

$65.66

0.1 (0.15%)

XLF

Financial Select Sector

$26.43

-0.085 (-0.32%)

XLI

Industrial Select Sector SPDR

$75.89

0.19 (0.25%)

XLY

Consumer Discretionary Sector SPDR

$110.81

0.31 (0.28%)

XLV

Health Care Select Sector SPDR

$92.29

0.59 (0.64%)

XLK

Technology Select Sector SPDR

$70.39

0.64 (0.92%)

SPY

SPDR S&P 500 ETF Trust

$278.35

0.92 (0.33%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:21
02/22/19
02/22
15:21
02/22/19
15:21
Conference/Events
House Appropriations Committee to hold a hearing »

The Subcommittee on…

RF

Regions Financial

$16.16

-0.085 (-0.52%)

15:20
02/22/19
02/22
15:20
02/22/19
15:20
Options
Call spreads in Regions Financial as bullish positions are adjusted »

Call spreads in Regions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
02/22/19
02/22
15:17
02/22/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
02/22/19
02/22
15:16
02/22/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UA

Under Armour

$19.57

0.16 (0.82%)

15:15
02/22/19
02/22
15:15
02/22/19
15:15
Options
Under Armour put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 06

    Mar

15:15
02/22/19
02/22
15:15
02/22/19
15:15
General news
Treasury Action: Treasuries have been underpinned all day »

Treasury Action:…

ABBV

AbbVie

$79.47

0.71 (0.90%)

, AZN

AstraZeneca

$40.78

0.345 (0.85%)

15:14
02/22/19
02/22
15:14
02/22/19
15:14
Conference/Events
Senate Finance Committee to hold a hearing »

The Committee holds a…

ABBV

AbbVie

$79.47

0.71 (0.90%)

AZN

AstraZeneca

$40.78

0.345 (0.85%)

BMY

Bristol-Myers

$50.75

0.6 (1.20%)

JNJ

Johnson & Johnson

$136.22

0.82 (0.61%)

MRK

Merck

$80.39

0.57 (0.71%)

PFE

Pfizer

$42.91

0.77 (1.83%)

SNY

Sanofi

$41.10

-0.23 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

MGA

Magna

$54.61

2.015 (3.83%)

15:04
02/22/19
02/22
15:04
02/22/19
15:04
Downgrade
Magna rating change  »

Magna downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

LTRPA

Liberty TripAdvisor

$16.20

0.31 (1.95%)

15:04
02/22/19
02/22
15:04
02/22/19
15:04
Options
Liberty TripAdvisor options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$278.32

0.89 (0.32%)

14:59
02/22/19
02/22
14:59
02/22/19
14:59
Periodicals
U.S. Treasury Secretary says U.S, China reach pact on currency issues, CNBC says »

Steven Mnuchin, U.S.…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.32

0.89 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:55
02/22/19
02/22
14:55
02/22/19
14:55
General news
Fed's Bullard doesn't want to be shrinking the balance sheet and cutting rates »

Fed's Bullard…

ALXN

Alexion

$128.46

0.9 (0.71%)

14:52
02/22/19
02/22
14:52
02/22/19
14:52
Hot Stocks
Alexion says FDA grants priority review and accepts sBLA of Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.